biOasis Technologies Ord Shs V.BTI.H

Alternate Symbol(s): BIOAF

Healthcare Biotechnology

Bioasis Technologies Inc. is a Canada-based biopharmaceutical company focused on research and development of technologies and products intended for the treatment of patients with nervous system, including central nervous system, diseases and disorders. The Company is engaged in the development of its xB 3 platform, which is a peptide-based technology, for the transport of therapeutic agents, in particular biological products, across the blood-brain barrier (BBB). It is focused on both orphan drug indications, including brain cancers, and rare genetic neurodegenerative diseases and neuroinflammatory conditions. The Company is also focused on its Epidermal Growth Factor (EGF) platform for treating rare and orphan neurodegenerative and neuroinflammatory disorders. EGF is a protein that stimulates cell growth and differentiation, notably for myelin producing cells. Its development programs include xB3-001: Brain Metastases, xB3-002: Glioblastoma and xB3-007: Neurodegenerative Disease.

TSXV:BTI.H - Post by User

biOasis Technologies Ord Shs

Bullboard Posts

Comment by neinsteinon Sep 15, 2016 10:35pm

100 Views

Post# 25243328

RE:RE:RE:RE:RE:RE:dilution at door step.

OK oilpatch. You hang on to your shares. 50,000, the magical 100,000 with a cost base of $1.05, or whatever fictious position you want to claim. It's irrelevant. But stop posting. Having an idiot like you continously posting on this forum does the (real) shareholders no favours. Best not to have the resident moron come across as representative of the shareholder base. I don't expect you to understand but you'd actually be helping yourself make some money.

nein

Bullboard Posts

BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient's Guide